Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils.
Leishmania parasites use polymorphonuclear neutrophils as intermediate hosts before their ultimate delivery to macrophages following engulfment of parasite-infected neutrophils. This leads to a silent and unrecognized entry of Leishmania into the macrophage host cell. Neutrophil function depends on its cytoplasmic granules, but their mobilization and role in how Leishmania parasites evade intracellular killing in neutrophils remain undetermined. Here, we have found by ultrastructural approaches that neutrophils ingested Leishmania major promastigotes, and azurophilic granules fused in a preferential way with parasite-containing phagosomes, without promoting parasite killing. Azurophilic granules, identified by the granule marker myeloperoxidase, also fused with Leishmania donovani-engulfed vacuoles in human neutrophils. In addition, the azurophilic membrane marker CD63 was also detected in the vacuole surrounding the parasite, and in the fusion of azurophilic granules with the parasite-engulfed phagosome. Tertiary and specific granules, involved in vacuole acidification and superoxide anion generation, hardly fused with Leishmania-containing phagosomes. L. major interaction with neutrophils did not elicit production of reactive oxygen species or mobilization of tertiary and specific granules. By using immunogold electron microscopy approaches in the engulfment of L. major and L. donovani by human neutrophils, we did not find a significant contribution of endoplasmic reticulum to the formation of Leishmania-containing vacuoles. Live Leishmania parasites were required to be optimally internalized by neutrophils. Our data suggest that Leishmania promastigotes modulate their uptake by neutrophils, and regulate granule fusion processes in a rather selective way to favor parasite survival in human neutrophils.
Mollinedo
Faustino
F
Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain. fmollin@usal.es
Janssen
Hans
H
de la Iglesia-Vicente
Janis
J
Villa-Pulgarin
Janny A
JA
Calafat
Jero
J
D000818:Animals; D003594:Cytoplasmic Granules / Q000378:metabolism*; D004721:Endoplasmic Reticulum / Q000378:metabolism / Q000469:parasitology; D006801:Humans; D007893:Leishmania donovani / Q000378:metabolism*; D018320:Leishmania major / Q000378:metabolism*; D016773:Leishmaniasis, Cutaneous / Q000378:metabolism*; D007898:Leishmaniasis, Visceral / Q000378:metabolism*; D008561:Membrane Fusion; D009504:Neutrophils / Q000378:metabolism* / Q000469:parasitology; D010588:Phagosomes / Q000378:metabolism / Q000469:parasitology; D014617:Vacuoles / Q000378:metabolism / Q000469:parasitology
J Immunol. 1995 Aug 15;155(4):2175-84
7636266
J Immunol. 1997 Jul 1;159(1):409-18
9200480
J Biol Chem. 1986 Jan 25;261(3):1077-82
3003052
J Immunol. 1986 Jun 1;136(11):4220-5
3009619
J Histochem Cytochem. 1984 Feb;32(2):165-71
6319482
Science. 2008 Aug 15;321(5891):970-4
18703742
Blood. 1997 Aug 1;90(3):1255-66
9242560
Blood. 1997 May 15;89(10):3503-21
9160655
Cell Microbiol. 2006 Apr;8(4):690-703
16548894
Blood. 2000 Oct 1;96(7):2574-83
11001914
Int J Cancer. 2000 Apr 15;86(2):208-18
10738248
Exp Parasitol. 2009 Jun;122(2):134-9
19303871
J Immunol. 1992 Jul 1;149(1):323-30
1607660
Placenta. 1999 Mar-Apr;20(2-3):185-8
10195740
Cell. 2002 Jul 12;110(1):119-31
12151002
Cell. 2005 Oct 7;123(1):157-70
16213220
Mol Cell Biochem. 1991 Jun 26;105(1):49-60
1656202
Blood. 2005 Mar 15;105(6):2549-56
15546957
J Biol Chem. 1995 Mar 3;270(9):4741-7
7876246
Cell Microbiol. 2006 Dec;8(12):1922-31
16848789
J Cell Biol. 1971 Oct;51(1):193-215
4329520
Biochem Biophys Res Commun. 1988 Jul 29;154(2):641-7
3135806
Immunol Today. 1999 Dec;20(12):535-7
10636641
Eur J Haematol. 1992 Oct;49(4):180-91
1464361
J Biol Chem. 1988 Jul 15;263(20):9946-51
2838485
J Med Microbiol. 1990 Jul;32(3):189-93
2374156
Biochem J. 1997 Nov 1;327 ( Pt 3):917-23
9581574
J Immunol. 2009 Sep 15;183(6):3690-9
19710472
Scand J Immunol. 1991 Jul;34(1):33-43
1676856
J Exp Med. 2001 Mar 19;193(6):777-84
11257143
Parasite Immunol. 1990 May;12(3):285-95
2385444
J Leukoc Biol. 2000 May;67(5):712-24
10811013
J Biol Chem. 1984 Jun 10;259(11):7143-50
6144682
J Immunol. 1981 Oct;127(4):1438-43
7276565
Eur J Immunol. 2006 Oct;36(10):2735-44
16955522
Blood. 1991 Aug 15;78(4):1105-11
1907873
FEBS Lett. 1987 Jun 15;217(2):158-62
3036578
Med Microbiol Immunol. 2001 Nov;190(1-2):73-6
11770115
Trends Microbiol. 2003 May;11(5):210-4
12781523
J Immunol. 2006 Sep 1;177(5):2831-41
16920918
Mol Pharmacol. 1989 Oct;36(4):547-55
2682203
J Med Microbiol. 1988 Feb;25(2):101-7
3276896
J Immunol. 2003 Jan 15;170(2):1034-42
12517971
Cell Microbiol. 2008 Jan;10(1):100-11
17651446
J Immunol. 2004 Dec 1;173(11):6521-5
15557140
J Biol Chem. 1992 Feb 25;267(6):3553-6
1740407